Clinical Trials List
Protocol NumberCLOU064A2302
Completed
2021-12-01 - 2024-01-05
Phase III
Terminated2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chin-Yi Yang 無
- 陳偉迪 無
- Yu-Huei Huang 無
- Hua-En Lee 無
- Chung-Yao Hsu 無
- Chun-Bing Chen 無
- Chun-Wei Lu 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
450 participants
